Author Archives: Jason Carr
Triumph Bancorp (TBK) Receives a Buy from Stephens
In a report released today, Matt Olney from Stephens maintained a Buy rating on Triumph Bancorp (TBK – Research Report), with a price target of $38. The company’s shares closed yesterday at $30.77. According to TipRanks.com, Olney is a 2-star
Microvision (MVIS) Receives a Buy from H.C. Wainwright
H.C. Wainwright analyst Kevin Dede reiterated a Buy rating on Microvision (MVIS – Research Report) today and set a price target of $3.50. The company’s shares closed yesterday at $1.03. According to TipRanks.com, Dede ‘s ranking currently consits of no
Microvision (MVIS) Gets a Buy Rating from Northland Securities
In a report released today, Michael Latimore from Northland Securities maintained a Buy rating on Microvision (MVIS – Research Report), with a price target of $2. The company’s shares closed yesterday at $1.03. According to TipRanks.com, Latimore is a 5-star
Elastic NV (ESTC) Receives a Buy from KeyBanc
In a report released yesterday, Brent Bracelin from KeyBanc maintained a Buy rating on Elastic NV (ESTC – Research Report), with a price target of $102. The company’s shares closed yesterday at $82.88. According to TipRanks.com, Bracelin is a top
Oppenheimer Sticks to Its Buy Rating for Rexnord Corporation (RXN)
In a report released yesterday, Bryan Blair from Oppenheimer reiterated a Buy rating on Rexnord Corporation (RXN – Research Report), with a price target of $34. The company’s shares closed yesterday at $27.75. Blair observed: “We expect RXN to report
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ionis Pharmaceuticals Inc (NASDAQ: IONS), Ultragenyx Pharmaceutical, Inc. (NASDAQ: RARE) and Array Biopharma (NASDAQ: ARRY)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ionis Pharmaceuticals Inc (IONS – Research Report), Ultragenyx Pharmaceutical, Inc. (RARE – Research Report) and Array Biopharma (ARRY – Research Report). Ionis Pharmaceuticals
